Hester Biosciences reports stronger Q4 profitability and improved FY26 performance, with standalone PAT up 174% in Q4 and ~64% for the year, while consolidated revenue grows 7% for FY26 and PAT rises sharply.
AI Assistant
Hester Biosciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.